163 filings
Page 2 of 9
SC 13E3
vihto
8 Mar 24
Going private transaction
5:32pm
SC 14D9
3mb5cd 35
8 Mar 24
Tender offer solicitation
5:21pm
SC TO-T
b57bd owzbbtd0
8 Mar 24
Third party tender offer statement
4:53pm
SC14D9C
ntnpbcqtik9gqx6g x7x
26 Feb 24
Written communication relating to third party tender offer
5:11pm
8-K
8gu3vsu
26 Feb 24
NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP
5:01pm
SC TO-C
ixg2557u6p mzwobh
26 Feb 24
Information about tender offer
4:53pm
8-K
w73ykrn5
22 Jan 24
Other Events
6:09am
8-K
5f9gtnmaqw8iyex1b
2 Jan 24
Other Events
7:30am
8-K
2ycgairhxxd6gnl7
4 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:19pm
8-K
c2yumcj 87qiaowya37
2 Nov 23
NGM Bio Reports Third Quarter 2023 Financial Results and Provides Business Highlights
4:06pm
8-K
jn1pj 8iqbuc0qr
17 Oct 23
Departure of Directors or Certain Officers
5:28pm
8-K/A
8six0z5
11 Sep 23
Departure of Directors or Certain Officers
4:01pm
8-K
pe3t5
11 Aug 23
Departure of Directors or Certain Officers
4:08pm
EFFECT
c7xxugctmm4450utqp3
7 Aug 23
Notice of effectiveness
12:15am
424B5
7u0w4gp
4 Aug 23
Prospectus supplement for primary offering
5:01pm
S-3/A
rfevljx5du8ytik2
4 Aug 23
Shelf registration (amended)
4:01pm
8-K
fhte xlion
3 Aug 23
NGM Bio Reports Second Quarter 2023 Financial Results and Provides Business Highlights
4:07pm
CORRESP
nnu79r5e10h5nin
1 Aug 23
Correspondence with SEC
12:00am